# OnCo record paper-pryma-high-specific-activity-i131-mibg-ppgl-jnm-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-pryma-high-specific-activity-i131-mibg-ppgl-jnm-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-pryma-high-specific-activity-i131-mibg-ppgl-jnm-2019" ;
  schema:name "Efficacy and safety of high-specific-activity 131I-MIBG therapy in advanced pheochromocytoma or paraganglioma"@en ;
  schema:description "A purified radioactive form of MIBG, taken up by adrenaline-producing tumour cells, let a quarter of patients halve their blood pressure medication for at least six months and shrank tumours in about one in five, leading to the first approved radiopharmaceutical for these tumours."@en ;
  schema:url <https://onco.cc/key-papers/paper-pryma-high-specific-activity-i131-mibg-ppgl-jnm-2019/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.2967/jnumed.118.217463>, <https://pubmed.ncbi.nlm.nih.gov/30291194/> ;
  schema:sameAs <https://doi.org/10.2967/jnumed.118.217463> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Pryma DA, Chin BB, Noto RB, et al." ;
  onco:cancers <https://onco.cc/cancers/metastatic-ppgl/> ;
  onco:drugs <https://onco.cc/drugs/i131-mibg/> ;
  onco:journals <https://onco.cc/journals/journal-of-nuclear-medicine/> .